Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Gold

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Frontiers in Medicine|May 29, 2024
Exploring regulatory flexibility to create novel incentives to optimize drug discoveryJacqueline A Sullivan, E Richard Gold
Lancet (London, England)|October 20, 2009
The missing ingredient in medicine patent poolsE Richard Gold, Jean-Frédéric Morin
Science (New York, N.Y.)|April 10, 2025
AI drug development's data problemE Richard Gold, Robert Cook-Deegan
Health Law Journal|January 30, 2004
Reconciling private benefit and public risk in biotechnology: xenotransplantation as a case study in consentE Richard Gold, Wendy A Adams
Lancet (London, England)|July 10, 2002
The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnologyE Richard Gold, Timothy A Caulfield
Medicine and Health, Rhode Island|July 19, 2007
Ocular melanomaIkue Shimizu, Richard Gold, Edward Feller
Global Policy|April 28, 2020
Promising Trends in Access to MedicinesE Richard Gold, Jean-Frédéric Morin
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 12, 2017
Gene patents still alive and kicking: their impact on provision of genetic testing for long QT syndrome in the Canadian public health-care systemSarah E Ali-Khan, E Richard Gold
Healthcare Policy = Politiques De Sante|June 10, 2022
Authors' Response - A Status Quo of Failure: Time to Fix University Technology Transfer to Address Global HealthMatthew Herder, E Richard Gold, Srinivas Murthy
Healthcare Policy = Politiques De Sante|June 10, 2022
University Technology Transfer Has Failed to Improve Access to Global Health Products during the COVID-19 PandemicMatthew Herder, E Richard Gold, Srinivas Murthy
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Frontiers in Medicine|May 29, 2024
Exploring regulatory flexibility to create novel incentives to optimize drug discoveryJacqueline A Sullivan, E Richard Gold
Lancet (London, England)|October 20, 2009
The missing ingredient in medicine patent poolsE Richard Gold, Jean-Frédéric Morin
Science (New York, N.Y.)|April 10, 2025
AI drug development's data problemE Richard Gold, Robert Cook-Deegan
Health Law Journal|January 30, 2004
Reconciling private benefit and public risk in biotechnology: xenotransplantation as a case study in consentE Richard Gold, Wendy A Adams
Lancet (London, England)|July 10, 2002
The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnologyE Richard Gold, Timothy A Caulfield
Medicine and Health, Rhode Island|July 19, 2007
Ocular melanomaIkue Shimizu, Richard Gold, Edward Feller
Global Policy|April 28, 2020
Promising Trends in Access to MedicinesE Richard Gold, Jean-Frédéric Morin
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 12, 2017
Gene patents still alive and kicking: their impact on provision of genetic testing for long QT syndrome in the Canadian public health-care systemSarah E Ali-Khan, E Richard Gold
Healthcare Policy = Politiques De Sante|June 10, 2022
Authors' Response - A Status Quo of Failure: Time to Fix University Technology Transfer to Address Global HealthMatthew Herder, E Richard Gold, Srinivas Murthy
Healthcare Policy = Politiques De Sante|June 10, 2022
University Technology Transfer Has Failed to Improve Access to Global Health Products during the COVID-19 PandemicMatthew Herder, E Richard Gold, Srinivas Murthy
Pageof 5